Yuan-Zhi Yuan (YuanZhi Yuan, Yuanzhi Yuan)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 6

Top Topics

Diabetic Retinopathy

Optical Coherence Tomography

Vascular Endothelial Growth Factor

Top Venues

Cell biology international

Oxidative medicine and cellular longevity

Journal of ophthalmology

Nature biomedical engineering

This page only lists publications with an associated author ORCID identifier.

Publications

Ruyi Yang, Peng Zhao, Liyang Wang, Chenli Feng, Chen Peng, Zhexuan Wang, Yingying Zhang, Minqian Shen, Kaiwen Shi, Shijun Weng, Chunqiong Dong, Fu Zeng, Tianyun Zhang, Xingdong Chen, Shuiyuan Wang, Yiheng Wang, Yuanyuan Luo, Qingyuan Chen, Yuqing Chen, Chengyong Jiang, Shanshan Jia, Zhaofei Yu, Jian K Liu, Fei Wang, Su Jiang, Wendong Xu, Liang Li, Gang Wang, Xiaofen Mo, Gengfeng Zheng, Aihua Chen, Xingtao Zhou, Chunhui Jiang, Yuan-Zhi Yuan, Biao Yan, Jiayi Zhang
Assessment of visual function in blind mice and monkeys with subretinally implanted nanowire arrays as artificial photoreceptors. Nature biomedical engineering (2023)
Ya-Hui Xu, Yi-Fan Feng, Rong Zou, Fei Yuan, Yuan-Zhi Yuan
Silencing of YAP attenuates pericyte-myofibroblast transition and subretinal fibrosis in experimental model of choroidal neovascularization. Cell biology international 46 (8) (2022)
Yi-Fan Feng, Xi Yang, Jinhai Huang, Minqian Shen, Liyang Wang, Xiuping Chen, Yuan-Zhi Yuan, Chunqiong Dong, Xiaoping Ma, Fei Yuan
Pharmacological Inhibition of Glutaminase 1 Attenuates Alkali-Induced Corneal Neovascularization by Modulating Macrophages. Oxidative medicine and cellular longevity 2022 (2022)
Rong Zou, Yahui Xu, Yifan Feng, Minqian Shen, Fei Yuan, Yuan-Zhi Yuan
YAP nuclear-cytoplasmic translocation is regulated by mechanical signaling, protein modification, and metabolism. Cell biology international 44 (7) (2020)
MinQian Shen, Yi-Fan Feng, Jing Wang, Yuan-Zhi Yuan, Fei Yuan
CXCR7 Inhibits Fibrosis via Wnt/β-Catenin Pathways during the Process of Angiogenesis in Human Umbilical Vein Endothelial Cells. BioMed research international 2020 (2020)
Fenghua Wang, Yuan-Zhi Yuan, Ling Wang, Xiaofeng Ye, Jingke Zhao, Mengxi Shen, Qi Zhang, Ding Xu, Guo-You Qin, Wei Zhang, Fei Yuan, Qing Chang, Pei-Quan Zhao, Fang Wang, Xiaodong Sun
One-Year Outcomes of 1 Dose versus 3 Loading Doses Followed by Pro Re Nata Regimen Using Ranibizumab for Neovascular Age-Related Macular Degeneration: The ARTIS Trial. Journal of ophthalmology 2019 (2019)